1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > 2016-2020 Infectious Disease Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

Complete report $11,500.  DataPack  (test volumes, sales forecasts, supplier shares) $7,500.

VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests performed in hospitals, blood banks, commercial laboratories, physician offices, public health, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

- Sales and market shares of major suppliers by individual test.

- Volume and sales forecasts for over 100 infectious disease assays by individual test and market segment:

Centralized Testing
- Hospitals
- Commercial/Private Laboratories
- Blood Banks
- Public Health Laboratories

POC/Decentralized Testing

- Physician Offices/Group Practices
- Emergency Rooms
- Operating/Recovery Suites
- ICUs/CCUs
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers

- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).

- Review of the market dynamics, trends, structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of over 100 major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,immunoassay, and other technologies and their potential applications for infectious disease testing.

- Global listings of companies developing or marketing infectious disease diagnostic products by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

- The companies analyzed in the report include:

   - Abbott
   - Affymetrix
   - Beckman Coulter/Danaher
   - Becton Dickinson
   - Biomerieux
   - Bio-Rad
   - Cepheid
   - Diamedix/Erba
   - Diasorin
   - Eiken Chemical
   - Elitech Group
   - Enzo Biochem
   - Fujirebio
   - Grifols
   - Hologic/Gen-Probe
   - ID Biomedical/GSK
   - Kreatech/Leica
   - Lonza
   - Ortho-Clinical Diagnostics
   - Qiagen
   - Roche
   - Scienion
   - Sequenom
   - SeraCare
   - Siemens
   - Takara Bio
   - ThermoFisher
   - Wallac/PE
   - Wako

Contains 1,060 pages and 192 tables

Table Of Contents

2016-2020 Infectious Disease Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations
I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Table of Contents
VI. Worldwide Overview of Major Tests,
Technologies, and Instrumentation
A. Major Infectious Disease Tests
1. AIDS
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA)
and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Chagas Disease
13. Chancroid
14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakob's Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori
Table of Contents
33. Hepatitis
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies
53. Respiratory Syncytial Virus (RSV)
54. RhinoViruses
55. RotaVirus (REOVIRUS)
56. Rubella(MEASLES)
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina
Table of Contents

B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Automated
and Semiautomated Analyzers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
VII. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
E. Market Size, Growth, Volume by Method, and Major Suppliers'
Sales and Market Shares by Test
Table of Contents
XI. Competitive Strategies
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako


List of Tables
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus
Tests
Major Companies Developing or Marketing Bartonella
Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida
Tests
Major Companies Developing or Marketing Chlamydia
Tests
Major Companies Developing or Marketing Clostridium
Tests
Major Companies Developing or Marketing Coronavirus
Tests
Major Companies Developing or Marketing Cryptosporidium
Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus
Tests
Major Companies Developing or Marketing Enterovirus
Tests
Major Companies Developing or Marketing EBV Tests

Major Companies Developing or Marketing Giardia
Tests
Major Companies Developing or Marketing Gonorrhea
Tests
Major Companies Developing or Marketing Hantavirus
Tests
Major Companies Developing or Marketing Helicobacter
Pylori Tests
Major Companies Developing or Marketing Hepatitis
Tests
Major Companies Developing or Marketing Herpes
Tests
Major Companies Developing or Marketing Influenza
Tests
Major Companies Developing or Marketing Legionella
Tests
Major Companies Developing or Marketing Lyme Disease
Tests
Major Companies Developing or Marketing Lymphogranuloma
Tests
Major Companies Developing or Marketing Malaria
Tests
Major Companies Developing or Marketing Measles
Tests
Major Companies Developing or Marketing Meningitis
Tests

Major Companies Developing or Marketing Microsporidium
Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma
Tests
Major Companies Developing or Marketing Papilloma
Virus Tests
Major Companies Developing or Marketing Parvovirus
Tests
Major Companies Developing or Marketing Pneumonia
Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus
Tests
Major Companies Developing or Marketing Rubella
Tests
Major Companies Developing or Marketing Salmonella
Tests
Major Companies Developing or Marketing Septicemia
Tests
Major Companies Developing or Marketing Shigella
Tests
Major Companies Developing or Marketing Staphylococci
Tests

Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing Syphilis
Tests
Major Companies Developing or Marketing Toxoplasmosis
Tests
Major Companies Developing or Marketing Trichomonas
Tests
Major Companies Developing or Marketing Tuberculosis
Tests
Major Companies Developing or Marketing West Nile
Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A. Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Laboratories Performing Infectious Disease Tests
by Market Segment
U.S.A.
Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
U.S.A.
Commercial/Private Laboratories Performing Infectious
Disease Tests by Annual Test Volume
U.S.A.
Physician Office Laboratories Performing Infectious
Disease Tests by Practice Size

U.S.A.
All Market Segments Infectious Disease Test Volume Forecast
U.S.A.
All Market Segments Infectious Disease Test Volume by Method
U.S.A.
Hospital Laboratories Infectious Disease Test Volume Forecast
U.S.A.
Blood Banks Infectious Disease Test Volume Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Public Health Laboratories Infectious Disease Test
Volume Forecast
U.S.A.
All Market Segments Infectious Disease Diagnostics
Market Forecast
U.S.A.
Hospital Laboratories Infectious Disease Diagnostics
Market Forecast
U.S.A.
Blood Banks Infectious Disease Diagnostics Market Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Diagnostics Market Forecast

U.S.A.
Public Health Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
HIV or HIV I/HIV II Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HIVAg Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Western Blot/Other Confirmatory Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S.A.
Adenovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Aeromonads Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
BEA Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Blastocystis Hominis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Campylobacter Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Candida Test Volume and Diagnostics Sales Forecast
by Market Segment

U.S.A.
Chancroid Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Chlamydia Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Coronavirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
CoxsackieVirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Cryptosporidium Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Cyclospora Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
CMV Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
E. Coli Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Echovirus Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.
Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
EBV Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Giardia Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Gonorrhea Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Granuloma Inguinale Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Hantavirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Helicobacter Pylori Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.
Hepatitis C Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Anti-HBC Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Anti-HBS Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Anti-HAV Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Hepatitis Delta Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HBcAg Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
HBeAg Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
ALT/SGPT Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment

U.S.A.
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Influenza Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Legionella Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Lyme Disease Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Lymphogranuloma Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Malaria Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Measles Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Meningitis Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Microsporidium Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Mononucleosis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Mumps Test Volume and Diagnostics Sales Forecast by Market
Segment

U.S.A.
Mycoplasma Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Papilloma Virus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.s.a.
Parvovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Pneumonia Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Polyomaviruses Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Pseudomonas Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Rabies
Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
RSV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Rotavirus Test Volume and Diagnostics Sales Forecast by Market
Segment

U.S.A.
Rubella Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Shigella Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Staphylococci Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Streptococci Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Syphilis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Trichomonas Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Tuberculosis Test Volume and Diagnostics Sales Forecast by
Market Segment

U.S.A.
Vibrio Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
West Nile Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Yersinia Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments
Infectious Disease Test Volume Forecast
U.S.A., Hospital Emergency Departments
Infectious Disease Reagent
and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated
Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers
Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers
Infectious Disease Test Volume Forecast
U.S.A., Ambulatory Care Centers Microbiology
And Serology Test Volume Forecast
U.S.A., Ambulatory Care Centers
Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Microbiology
and Serology Reagent and Instrument Sales Forecast

U.S.A., Surgery Centers Most
Frequently Performed Procedures
U.S.A., Surgery Centers Microbiology
and Serology Test Volume Forecast
U.S.A., Surgery Centers Microbiology
And Serology Reagent and Instrument Sales Forecast
U.S.A., Birth Centers Facilities,
Patient Visits, and Births
U.S.A., Birth Centers Microbiology
and Serology Test Volume Forecast
U.S.A.
AIDS Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Adenovirus Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Campylobacter Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Candida Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Chancroid Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Chlamydia Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
CMV Testing Market Diagnostics Sales by Major
Supplier

U.S.A.
Cryptosporidium Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Echovirus Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Enterovirus Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
EBV Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Giardia Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Gonorrhea Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Helicobacter Pylori Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Hepatitis Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Hepatitis C Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Herpes Testing Market Diagnostics Sales by Major
Supplier

U.S.A.
Influenza Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Legionella Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Lyme Disease Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Measles Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Meningitis Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Mononucleosis Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Mumps Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Mycoplasma Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Pneumonia Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Rabies Testing Market Diagnostics Sales by Major
Supplier

U.S.A.
RSV Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Rotavirus Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Rubella Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Salmonella Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Septicemia Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Shigella Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Streptococci Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Syphilis Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Toxoplasmosis Testing Market Diagnostics Sales by
Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


Download Unlimited Documents from Trusted Public Sources

Infectious Disease Statistics in South Africa

  • November 2016
    9 pages
  • Infectious Dise...  

  • South Africa  

    Africa  

View report >

Infectious Disease Statistics in France

  • November 2016
    3 pages
  • Infectious Dise...  

    Shellfish  

    Oyster  

  • France  

View report >

Pathology Statistics in Spain

  • November 2016
    3 pages
  • Pathology  

    Infectious Dise...  

  • Spain  

    Europe  

View report >

Related Market Segments :

Infectious Disease
Diagnostics

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.